COVID-19

News

J&J joins COVID-19 booster shot drive, filing with FDA

Johnson & Johnson's COVID-19 vaccine has been a minor player in the US vaccination drive so far, but the company hopes it can have a bigger role as a booster shot.

News

AZ files for emergency use of COVID-19 antibody combo in US

AstraZeneca has sought emergency use authorisation for its antibody combination AZD7442, following trial results indicating it can prevent symptomatic COVID-19 infection when given to healt

News

Targeting COVID-19 and cancer with immunotherapy advancements

EU backs broader use of Comirnaty as COVID booster than US

The EMA has given the go-ahead to the use of Pfizer and BioNTech's COVID-19 vaccine Comirnaty as a booster for all people aged 18 or more, but says EU member states must decide for themselv

R&D

Novartis’ Amit Nastik on COVID’s supply chain impact: the ph...

Episode 41 of the pharmaphorum podcast heard from Amit Nastik about the impact of COVID-19 on pharma supply chains and how he and his team mitigated disruption to Novartis’ own operations.<

News

Merck preps filings for oral COVID drug, but is it really a ...

Merck & Co is on the brink of plugging a gap in the coronavirus treatment armamentarium after its oral drug molnupiravir cut deaths and hospitalisations in mild or moderate COVID-19 in

News

Novartis tightens up its COVID-19 vaccine policy for staff

Novartis has joined a growing number of companies insisting that its workforce is double vaccinated against COVID-19 if they want to work at one of its sites.

J&J joins COVID-19 booster shot drive, filing with FDA

AZ files for emergency use of COVID-19 antibody combo in US

EU backs broader use of Comirnaty as COVID booster than US

Novartis’ Amit Nastik on COVID’s supply chain impact: the ph...

Merck preps filings for oral COVID drug, but is it really a ...

Novartis tightens up its COVID-19 vaccine policy for staff

Recordati gets €10.9bn takeover bid from private equity firm

Using AI-driven synthetic personas to take your insights fur...

COVID-19

Editor's Picks